Raymond James Financial Inc. Takes Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Raymond James Financial Inc. acquired a new stake in Stereotaxis, Inc. (NYSEAMERICAN:STXS) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 44,350 shares of the company’s stock, valued at approximately $101,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. SG Americas Securities LLC grew its holdings in shares of Stereotaxis by 39.2% during the fourth quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock valued at $60,000 after purchasing an additional 7,417 shares during the last quarter. Jane Street Group LLC boosted its stake in Stereotaxis by 26.9% during the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after buying an additional 6,313 shares in the last quarter. Wealth Effects LLC lifted its stake in Stereotaxis by 11.7% during the fourth quarter. Wealth Effects LLC now owns 86,060 shares of the company’s stock valued at $196,000 after purchasing an additional 9,000 shares during the last quarter. Barclays PLC raised its position in shares of Stereotaxis by 449.9% during the third quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after purchasing an additional 83,412 shares during the period. Finally, Kovack Advisors Inc. raised its holdings in shares of Stereotaxis by 8.0% during the fourth quarter. Kovack Advisors Inc. now owns 133,792 shares of the company’s stock valued at $305,000 after acquiring an additional 9,917 shares during the period. 45.35% of the stock is currently owned by institutional investors and hedge funds.

Stereotaxis Stock Performance

STXS stock opened at $1.66 on Friday. The firm has a market cap of $140.65 million, a PE ratio of -5.93 and a beta of 1.54. Stereotaxis, Inc. has a 1 year low of $1.54 and a 1 year high of $2.95. The company has a fifty day simple moving average of $2.02 and a 200 day simple moving average of $2.07.

Insider Activity at Stereotaxis

In related news, Director Paul J. Isaac bought 38,000 shares of Stereotaxis stock in a transaction on Monday, March 10th. The shares were purchased at an average price of $1.81 per share, for a total transaction of $68,780.00. Following the completion of the acquisition, the director now owns 87,299 shares in the company, valued at approximately $158,011.19. This represents a 77.08 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 18.52% of the stock is currently owned by corporate insiders.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.